These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15060187)

  • 1. Risk assessment and child health.
    Samet JM
    Pediatrics; 2004 Apr; 113(4 Suppl):952-6. PubMed ID: 15060187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lifestage-specific approach to hazard and dose-response characterization for children's health risk assessment.
    Makris SL; Thompson CM; Euling SY; Selevan SG; Sonawane B
    Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):530-46. PubMed ID: 19085945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lifestage approach to assessing children's exposure.
    Cohen Hubal EA; Moya J; Selevan SG
    Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):522-9. PubMed ID: 19025791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Background to the ADI/TDI/PTWI.
    Herrman JL; Younes M
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S109-13. PubMed ID: 10597623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicological comments to the discussion about REACH.
    Greim H; Arand M; Autrup H; Bolt HM; Bridges J; Dybing E; Glomot R; Foa V; Schulte-Hermann R
    Arch Toxicol; 2006 Mar; 80(3):121-4. PubMed ID: 16411136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health effects classification and its role in the derivation of minimal risk levels: renal effects.
    Chou CH; Pohl HR
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):202-8. PubMed ID: 15921839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally occurring asbestos: a recurring public policy challenge.
    Lee RJ; Strohmeier BR; Bunker KL; Van Orden DR
    J Hazard Mater; 2008 May; 153(1-2):1-21. PubMed ID: 18180100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate.
    Hasegawa R; Koizumi M; Hirose A
    Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing risks.
    Kasamatsu T; Kohda K
    Regul Toxicol Pharmacol; 2006 Oct; 46(1):100-4. PubMed ID: 16843577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling population exposures to outdoor sources of hazardous air pollutants.
    Ozkaynak H; Palma T; Touma JS; Thurman J
    J Expo Sci Environ Epidemiol; 2008 Jan; 18(1):45-58. PubMed ID: 17878926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicological resources for cumulative risk: an example with hazardous air pollutants.
    Fox MA; Tran NL; Groopman JD; Burke TA
    Regul Toxicol Pharmacol; 2004 Dec; 40(3):305-11. PubMed ID: 15546684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of health information in air pollution health research: past successes and emerging needs.
    Thurston GD; Bekkedal MY; Roberts EM; Ito K; Pope CA; Glenn BS; Ozkaynak H; Utell MJ
    J Expo Sci Environ Epidemiol; 2009 Jan; 19(1):45-58. PubMed ID: 18781194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential new approaches for children's inhalation risk assessment.
    Firestone M; Sonawane B; Barone S; Salmon AG; Brown JP; Hattis D; Woodruff T
    J Toxicol Environ Health A; 2008; 71(3):208-17. PubMed ID: 18097946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
    Brent RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment of oral exposure to diisononyl phthalate from children's products.
    Babich MA; Chen SB; Greene MA; Kiss CT; Porter WK; Smith TP; Wind ML; Zamula WW
    Regul Toxicol Pharmacol; 2004 Oct; 40(2):151-67. PubMed ID: 15450718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative estimates of risk for noncancer endpoints.
    Clewell HJ; Crump KS
    Risk Anal; 2005 Apr; 25(2):285-9. PubMed ID: 15876204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Options for incorporating children's inhaled dose into human health risk assessment.
    Ginsberg G; Foos B; Dzubow RB; Firestone M
    Inhal Toxicol; 2010 Jul; 22(8):627-47. PubMed ID: 20540622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between children and adults: implications for risk assessment at California EPA.
    Miller MD; Marty MA; Arcus A; Brown J; Morry D; Sandy M
    Int J Toxicol; 2002; 21(5):403-18. PubMed ID: 12396687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.